Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success – WSJ

16 hours ago

1 Views

1 Min Read

Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success WSJ
Eli Lilly stock jumps on retatrutide Phase 3 weight loss results qz.com
Triple-action diabetes jab shown to reduce blood sugar and body weight The Guardian
Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits Reuters
Retatrutide Data Show Dramatic Weight Loss, Other Benefits Medscape